|
|
Recent Abstracts
AABB Annual Meeting & CTTXPO 2010
October 9 - 12, 2010 | Baltimore, Maryland, USA
- J Cancelas, N Rugg, L Dumont et al. Comprehensive Evaluation of a New Process for S-303 Pathogen-Inactivation of Red Blood Cells.
- M Lozano, F Knutso, R Tardivel et al. Frequency of Prophylactic Transfusion Failure: A Novel Outcome To Evaluate Platelet Components Stored More Than 5 Days.
- E Girona-Llobera, A Galmés-Trueba, T Jimenez-Marco et al. Platelet Pathogen Inactivation Improve Platelet Components Manage- ment and Lowering the Production Cost Associated with Expiration.
- A K North, R Henschler, C Geisen et al. Evaluation of Naturally Occurring Antibodies to Pathogen Inactivated Red Blood Cells.
- J Mikovits, K Hagen, C Sadowski et al. Inactivation of XMRV by the INTERCEPT Blood SystemTM in Platelet Concentrates.
[Poster PDF]
- R Henschler, K Janetzko, B Erterek et al. Evaluation of the S-303 Pathogen Inactivation (PI) System with RBC Components Using US and EU Processing Practices.
[Poster PDF]
1st International Workshop on XMRV
September 7 - 8, 2010 | Bethesda, Maryland, USA
- J A. Mikovits, K Hagen, W Liu, D Hanson, C Sadowski, V KewalRamani, KG Lee, W. Ruscetti, L Lin. Inactivation of XMRV and MLV-related Viruses in Platelet and RBC Components Prepared with the INTERCEPT Blood System.
[Poster PDF]
For more conference abstracts, visit the INTERCEPT website
|
